PBD dimer

SGD-1882 (PBD dimer) 是一种有细胞毒性的偶联剂，是靶向小鼠和人造血干细胞 （HSC） 和急性髓性白血病细胞的载荷。

PBD dimer-2（化合物2c）是一种通过C8连接的吡咯苯二氮卓二聚体。该化合物能跨越一个额外碱基对，与5'-Pu-GA(T A)TC-Py序列交联。PBD dimer-2作为有效载荷，在抗体-活性分子偶联物（ADC）中用于癌症研究具有重要价值。

SG2057 (DRG16) 是一种含有戊二氧基键的 PBD 二聚体，该键选择性地结合DNA 小沟中的序列，形成 DNA 链间和链内交联加合物。SG2057 是一种高效抗肿瘤剂。

Dimethyl-SGD-1882 (Dimethyl-PBD dimer) is a highly efficient DNA alkylating agent used as an antibody-drug conjugate (ADC) cytotoxin, inhibiting DNA replication.

MP-PEG8-VA-PABC-PBD Dimer is a drug-linker conjugates for ADC which is used in the treatment of several cancers. PBD Dimer is a DNA alkylating which inhibits DNA replication[1].

SG3199 is a PBD dimer which binds in the minor groove of DNA, and forms covalent DNA interstrand cross-links in naked linear plasmid DNA. SG3199 is potently cytotoxic against a panel of human solid tumour and haematological cancer cell lines.

DGN549-C is a novel compound featuring a cleavable ADC (antibody-drug conjugate) linker composed of valine-alanine (va) and a PBD (pyrrolobenzodiazepine) dimer. This compound possesses a unique DNA-alkylating cytotoxic payload, DGN549, which is utilized in the development of ADCs.

Mipasetamab uzoptirine (ADCT-601) 是一种 AXL 靶向的抗体-活性分子偶联物(ADCs)。Mipasetamab uzoptirine 由人源化抗 AXL 抗体、可裂解连接子和有效的吡咯并苯二氮卓 (PBD) 二聚体细胞毒素 SG3199 组成。Mipasetamab uzoptirine 可用于癌症研究。

Tomaymycin DM，一种Tomaymycin衍生的DNA烷化剂，作为肿瘤靶向抗体偶联活性分子(ADCs)有效载荷，是PBD单体。

PBD-monoamide, a modified pyrrolobenzodiazepine (PBD) dimer, functions as an ADC cytotoxin. It is utilized in synthesizing DHES0815A (an HER2 ADC) and possesses DNA-binding activity that reduces cell viability [1].

Serclutamab talirine (ABBV-321) 作为一种EGFR靶向抗体药物偶联物 (ADC)，由专门针对激活EGFR的抗体 (AM-1-ABT-806) 与吡咯苯二氮卓 (PBD) 二聚体构成，展现出显著的抗肿瘤活性。